NEXGARD FOR MEDIUM DOGS

Description

NexGard is a tasty, chewable tablet that dogs love and is convenient and affordable. It kills both ticks and fleas quickly and effectively, with continued protection for a full 30 days.

CHEWABLE TABLETS FOR DOGS

FOR ANIMAL USE ONLY.

NEXGARD® contains afoxolaner, an insecticide-acaricide for oral treatment and prevention of flea and tick infestations of dogs for one month following a single administration.

INDICATIONS

• For the treatment and prevention of flea infestation in dogs (Ctenocephalides felis and C. canis) for at least 1 month.
• Starts killing existing fleas 30 minutes after administration; 100% efficacy achieved by 8 hours.
• Elimination of new adult fleas on the dog within 12 hours; kills fleas before egg production and therefore prevents the risk of household contamination.
• Can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
• For the treatment and prevention of tick infestation in dogs (Rhipicephalus sanguineus, Haemaphysalis spp.) plus various other spp.
• For optimal flea and tick control monthly administrations are recommended.

COMPOSITION

Afoxolaner 2,27 % w/w.

DOSAGE AND DIRECTIONS FOR USE

• Use only as directed.
• Administer orally at monthly intervals to provide the recommended dosage of 2, 5 mg/kg of afoxolaner per kg bodyweight.
• For dogs above 50 kg, administer the appropriate combination of chewable tablets.
• NEXGARD® is recommended for use in dogs and puppies 8 weeks of age and older

WARNINGS

• Keep out of reach of children, uninformed persons and animals.
• After treatment with NEXGARD®, most ticks will generally be killed within 48 hours after infestation. However the attachment of single ticks cannot be excluded and so transmissione completely excluded if conditions are unfavourable.
• NEXGARD® may cause vomiting and diarrhoea in some dogs.

Use during pregnancy, lactating or breeding:

• No data have been generated in dogs used for breeding. However, in laboratory species (rats and rabbits), afoxolaner has not produced any evidence of teratogenic effects, nor any adverse effect on the reproductive capacity in males and females.
• Safety in pregnant and lactating animals has not been determined.
• Although this remedy has been extensively tested under a large variety of conditions, failure thereof may ensure as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.